title: An updated medical position statement of the North American Society for Pediatric Gastroenterology and Nutrition.
authors.forename: R J
authors.initials: RJ
authors.lastname: Shulman
authors.forename: J T
authors.initials: JT
authors.lastname: Boyle
authors.forename: R B
authors.initials: RB
authors.lastname: Colletti
authors.forename: R
authors.initials: R
authors.lastname: Friedman
authors.forename: M B
authors.initials: MB
authors.lastname: Heyman
authors.forename: G
authors.initials: G
authors.lastname: Kearns
authors.forename: B S
authors.initials: BS
authors.lastname: Kirschner
authors.forename: J
authors.initials: J
authors.lastname: Levy
authors.forename: A A
authors.initials: AA
authors.lastname: Mitchell
authors.forename: G
authors.initials: G
authors.lastname: Van Hare
mesh_terms: D002648:Child; D020117:Cisapride / Q000009:adverse effects / Q000627:therapeutic use*; D000075202:Contraindications; D005765:Gastrointestinal Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D012449:Safety; D016896:Treatment Outcome
chemical_list: D005765:Gastrointestinal Agents; D020117:Cisapride